Back to Agenda
Innovations in Managing Global Clinical Supplies
Session Chair(s)
Mark Wade
Global Practice Leader Life Sciences
TransPerfect, United States
This session is focused on examining the choke points of label creation and execution. Virtually all studies have an international component, what methodologies and technologies can be leveraged to streamline an already intricate process? This session will examine an exciting new eLabel initiative and communicate what TransCelerate is doing to assist with industry uptake and influencing health authorities. In addition this session will focus on the future or randomization and trial supply management and understanding the shift to self-service, configurable tools. This session will review industry trends and approaches and benefits to moving your organization towards the future with RTSM capabilities.
Learning Objective : Describe efficiencies to streamline global label creation and execution; Discuss eLabel new industry and health authorities initiatives; Identify the future of randomization and trial supply management (RTSM) and clinical supplies technologies.
Speaker(s)
Uncorking the Bottleneck in Labeling for Investigational Medicinal Products in Multicultural Clinical Trials
Mark Wade
TransPerfect, United States
Global Practice Leader Life Sciences
The Near-Term Viability and Benefits of eLabels for Clinical, Sites, and Patients
Hans Von Steiger
Pfizer Inc, United States
Director / Team Leader
The Future of Randomization and Trial Supply Management
Jennifer Bush, MS
Oracle , United States
Director Life Sciences Product Strategy
Have an account?